Article

Analysis of disease-associated ND4 mutations: how do we know which mutation is pathogenic?

Department of Pathology, Mackay Memorial Hospital, Taipei, Taiwan.
Mitochondrion (impact factor: 3.62). 7(1-2):151-6. DOI:10.1016/j.mito.2006.11.007 pp.151-6
Source: PubMed

ABSTRACT It is not uncommon to identify more than one mtDNA replacement mutations in the specimens from patients. However, we usually do not know if the identified mtDNA mutation is pathogenic or not. Even functional assays are available to use, we would not know which mutation(s) is to be tested. To provide a rapid method for initial evaluation for the pathogenicity of the replacement mutation, we compared three evolutional analyses: primate conservation index (PCI), mammalian conservation index (MCI), and conservation index across a wide spectrum of species (CI). After analyzing 35 so-called diseases-associated replacement mutations of ND4, we found 8 pathogenic mutations, 15 nonpathogenic mutations, and 12 mutations of undetermined significance. The MCI classification appears to be the best one among the three systems. This study demonstrates that evolutional analysis can serve as a rapid evaluation for the pathogenicity of mtDNA replacement mutations.

0 0
 · 
0 Bookmarks
 · 
13 Views

Keywords

12 mutations
 
15 nonpathogenic mutations
 
35 so-called diseases-associated replacement mutations
 
8 pathogenic mutations
 
conservation index
 
evolutional analyses
 
evolutional analysis
 
functional assays
 
identified mtDNA mutation
 
initial evaluation
 
mammalian conservation index
 
mtDNA replacement mutations
 
one mtDNA replacement mutations
 
patients
 
primate conservation index
 
rapid evaluation
 
rapid method
 
replacement mutation
 
undetermined significance
 
wide spectrum
 

Chin-Yuan Tzen